Purpose: To investigate the 1-year outcomes of transvenous intravascular ultrasound (IVUS)-guided endovascular therapy (EVT) for chronic total occlusion (CTO) of the lower extremity arteries. Methods: Transvenous IVUS-guided EVT was performed in 44 patients (50 limbs) with CTO of the femoropopliteal arteries or tibioperoneal trunk. Treatment involved crossing a guidewire through the CTO under the guidance of both fluoroscopic and IVUS imaging, along with insertion of the IVUS catheter into a vein parallel to the target artery. Primary success rate, complications, and target lesion revascularization (TLR) at 12-month follow-up were investigated. Results: Successful recanalization, defined as grade 3 flow (Thrombolysis in Myocardial Infarction score) and no flow-limiting dissection, was observed in 48 (96%) limbs. Two limbs with failed recanalization had a very long CTO lesion from the superficial femoral artery to below the knee. A bidirectional approach was selected in 11 (22%) limbs. Complications at the access site occurred in only 2 patients. The rate of freedom from TLR at 12 months was 77.9% (95% confidence interval 61.4 to 87.9). Conclusion: Transvenous IVUS-guided EVT is safe and can provide optimal short-term results for EVT of CTO in the infrainguinal arteries. IVUS-guided EVT may be one of the most effective treatment strategies for CTO of the femoropopliteal arteries or tibioperoneal trunk.
Introduction
Endovascular treatment (EVT) plays an increasingly significant role in the treatment of peripheral artery diseases (PAD). 1 Previously, EVT for chronic total occlusion (CTO) of lower extremity arteries did not provide good primary success rates because of the frequent inability to cross the occluded site with a guidewire. In recent years, there have been major advances in CTO crossing techniques, and high success rates have been achieved. [2] [3] [4] [5] [6] Although advances have been made in duplex-guided recanalization, [2] [3] [4] retrograde approaches, 5, 6 and subintimal angioplasty with a reentry device, 7, 8 these solutions are not without their own problems. Because of these limitations, safe and reliable treatment strategies are required.
There are a few previous reports on the early experimentation with intravenous intravascular ultrasound (IVUS) for arterial visualization. [9] [10] [11] More recently, Hishikari et al 12 reported endovascular treatment of aortoiliac CTO using intravenous IVUS. With the above in mind, a study was conducted to evaluate our treatment strategy for infrainguinal CTOs using transvenous IVUS imaging to guide recanalization.
Methods

Patient Selection
A retrospective analysis was conducted of 44 patients (mean age 78.7±7.3 years; 29 men) who underwent EVT for 50
CTOs using transvenous IVUS guidance at the operator's discretion over a 3-year period. During the study period, another 9 infrainguinal CTOs were treated without IVUS interrogation. In 8 cases, the operator judged that IVUS guidance was not necessary because of short lesion length (<60 mm). Although the other case involved a long CTO (440 mm), IVUS imaging was not used because of preexisting deep vein thrombosis. Written informed consent was obtained from all patients prior to treatment. Data were gathered from medical records regarding baseline and angiographic characteristics, acute outcomes, and complications associated with the procedure. Data regarding clinically driven target lesion revascularization (TLR) at 12 months after treatment were obtained from medical records or telephone surveys. The institutional review board at The Fraternity Memorial Hospital approved the study protocol.
The study patients displayed a typical spectrum of cardiovascular risk factors consistent with PAD (Table 1) . About half the population had Rutherford category 4/5 critical limb ischemia (CLI; Table 1 ). The CTOs were located principally in the superficial femoral artery (SFA; 37, 74%); 10 (20%) were in the popliteal artery and 3 (6%) in the tibioperoneal trunk (Table 2) . Runoff was poor (≤1 vessel) in 22 of the 50 target limbs. Angiographically determined calcification was moderate to severe in half of the CTOs.
Procedure
Arterial and venous accesses were acquired using an ipsilateral antegrade, a contralateral crossover, or a bidirectional approach depending on the occluded site. In the ipsilateral antegrade approach, a conventional sheath or a homemade side-hole sheath ( Figure 1 ) was used in 30 and 9 cases, respectively; in the contralateral approach, a guiding sheath was used. Heparin was administered intravenously to all patients.
The physician-modified side-hole sheath featured a 2×7-mm oval side hole ~7 cm from the tip of the sheath, which was antegradely introduced into the deep femoral artery (DFA) through the common femoral artery (CFA). The side hole was positioned at the level of the SFA orifice and was oriented toward the entrance of the SFA. The guidewire easily penetrated the CTO lesion via the side hole of the modified sheath using strong backup force.
In transvenous IVUS-guided EVT (Figure 2  13 ), a guidewire was advanced through the CTO under fluoroscopic and IVUS guidance provided by an IVUS catheter inserted in a vein running parallel to the target artery ( Figure 2A ). An 8-F sheath was introduced via the common femoral vein, and a 0.035-inch Radifocus guidewire (Terumo Corporation, Tokyo, Japan) was inserted into the superficial femoral vein with milking to open the venous valves. Appropriate stiff CTO guidewires (0.018-or 0.014-inch) were used at the operator's discretion. The guidewire was advanced to the popliteal vein or further in cases of popliteal or tibioperoneal trunk CTOs. With a 10-MHz Visions PV .035 catheter (Philips Volcano Corporation, San Diego, CA, USA) in the vein, guidewire placement at different stages were ascertained (indicated by a gray circle, triangle, and square in Figure 2B ). If the guidewire was in the desired position (gray circle in Figure 2B ) it was advanced further. If the guidewire was out of position (gray triangle or square in Figure 2B ), the guidewire was not advanced further but instead pulled back to its previous correct position before being advanced further. Although transvenous IVUS did not supply optimal images in a few areas of the CTO, it was assumed that if a guidewire was in 2 intraplaque areas of the CTO lesion, the area between the 2 was likely the intraplaque area. A guidewire was generally used with a support catheter, and the lesion was dilated using an angioplasty balloon after the CTO was successfully crossed with a guidewire. A nitinol stent was deployed in case of dissection or significant recoil.
The application of transvenous IVUS guidance is illustrated in an 81-year-old man with intermittent claudication owing to a right SFA CTO ( Figure 3A) . A 6-F side-hole sheath was inserted via the CFA in the antegrade direction (see Figure 1C ). The tip of the side-hole sheath was positioned at the DFA, and a guidewire was advanced into the SFA through the side hole. The IVUS catheter was introduced via an 8-F sheath into the superficial femoral vein via the common femoral vein. Initial angiography showed total occlusion of the SFA with a very short stump ( Figure 3B ). The femoral bifurcation ( Figure 4A -C) and a region just past the occlusion (Fig 4D-F) could be clearly seen by the intravenous IVUS catheter.
Guidewire crossing of the occlusion was performed with concurrent fluoroscopic and IVUS imaging. At the level of the lesser trochanter, IVUS showed the guidewire had advanced to the edge of the vessel, which was not the intention ( Figure 4G-I ). As the guidewire was judged to be in the subintimal area, it was retracted to the correct position and advanced again so that it was near to the center of the vessel according to the IVUS image (intraplaque area; Figure  5A -C). The guidewire was advanced further using the transvenous IVUS technique and could be seen near the center of the vessel but not at its edge near the distal cap ( Figure  5D-F) . Finally, the guidewire was advanced through the distal cap, and IVUS along with fluoroscopic images ( Figure  5F -I) confirmed that the guidewire was in the true lumen (nonocclusive site). Two self-expanding stents were deployed in the occlusion and postdilated ( Figure 6A and  B) . Final angiography demonstrated optimal recanalization of the lesion ( Figure 6C ).
Statistical Analysis
Continuous data are presented as means ± standard deviations or median (interquartile range). Categorical data are shown as counts (percentages). The freedom from TLR at 12 months was analyzed using Kaplan-Meier time-to-event methods; the estimate is reported with the 95% confidence intervals (CI). All statistical analyses were performed using EZR (version 1.30; available at http://www.jichi.ac.jp/ saitama-sct/SaitamaHP.files/statmedEN.html).
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Results
Acute outcomes and complications are shown in Table 3 . Successful recanalization, defined as grade 3 flow according to the Thrombolysis in Myocardial Infarction score and no flow-limiting dissection, was observed in 48 (96%) limbs including 23 (92%) of 25 patients with moderate or severe calcification. The 2 failed cases were long CTOs from the SFA to the infragenicular segment, and a guidewire could not traverse the lesion. Accurate IVUS images could not be obtained in these cases because of severe calcification. Of note, in 15 of the 23 moderately or severely calcified CTOs, only the antegrade approach was used. Nine of the 37 SFA CTOs and 12 of the 13 popliteal or tibioperoneal lesions had no stent deployed.
Two perioperative complications were encountered, both associated with the vascular access sites. One hematoma required a blood transfusion, and the collagen plug of an Angio-Seal closure device migrated and occluded the CFA; the plug was removed surgically. There were no complications such as venous insufficiency or venous thromboembolism associated with intravenous IVUS insertion. The rate of freedom from TLR ( Figure 7 ) at 12 months was 77.9% (95% CI 61.4 to 87.9).
Discussion
EVT and bypass surgery are invasive treatment strategies for patients with CTO associated with PAD. Although bypass surgery is recommended for long CTOs in the infrainguinal arteries, 15 a few patients do not tolerate invasive bypass surgery due to the presence of certain risk factors. 16 EVT is less invasive and can be performed in high-risk patients. Recently, the number of EVT procedures for PAD, including CTO, has been increasing. 1 The primary success rate of EVT for lower extremity CTOs is lower than that for simple stenotic lesions, largely due to failures of guidewire crossing. Although this problem has been reduced to a great extent by advances in various devices and procedures, such as duplexguided recanalization, 2-4 retrograde approaches, 5, 6 and subintimal angioplasty with a reentry device, 7 these solutions are not without their own problems.
Duplex-guided recanalization requires an echo technician whose hand is often exposed to radiation in cases involving concurrent fluoroscopy. When using the retrograde approach for SFA lesions, patients must be repositioned during the procedure when the approach site is the popliteal artery. Furthermore, the retrograde approach (including bidirectional) does not generally ensure intimal tracking of the guidewire because CTO crossing is under fluoroscopic guidance only. Although subintimal angioplasty has most commonly been performed in SFA CTOs, stent deployment is usually needed, and there is a risk of arterial perforation during subintimal balloon dilation. 8 IVUS-guided EVT has been performed for some time in the coronary arteries. This method involves manipulating a guidewire with reference to an IVUS catheter inserted into the false lumen distal to the CTO. 17 This method is also associated with certain limitations. First, it is possible that insertion of an IVUS catheter could dilate the false lumen, including the subintimal area, making stent deployment likely or causing difficulties in guidewire manipulation. Second, the simultaneous insertion of an IVUS catheter and a guidewire into the same vessel could similarly make it difficult to manipulate the guidewire. Third, in cases of severely calcified lesions, an IVUS catheter may be able to pass through the hard lesion, making it impossible to manipulate the guidewire while simultaneously viewing the IVUS image.
In the current study, a 96% success rate was achieved in CTO recanalization despite a by and large elderly population with CLI in >50%, lengthy lesions (median 180 cm), and various degrees of calcification. An optimal image of the CTO was obtained in almost all cases owing to the 10-MHz IVUS catheter. The attenuation of echo signals is generally lower with this type of catheter than with 20-and 40-MHz models, which are mostly used in EVT of lower extremity arteries. The 10-MHz IVUS catheter allowed visualization of the guidewire in the occluded segment distant from the vein and through calcification. Even in cases with severe calcification, the target artery was visualized in a few areas of the CTO, thereby allowing navigation of the guidewire to the intimal area. These results suggest that transvenous IVUS-guided EVT is useful even in cases with moderate or severe calcification.
Although the majority of the target lesions in this study were in the SFA, 13 were in the popliteal artery or tibioperoneal trunk, unfavorable sites for subintimal angioplasty due to small caliber and the presence of a nonstenting zone. However, no stents were needed in the majority of cases, which suggests that guidewires traverse the intraplaque region rather than the subintimal plane using the transvenous IVUS technique.
An ipsilateral antegrade or crossover approach was successfully used in three quarters of the limbs due in large part to the transvenous IVUS technique; typically, the success rate of antegrade guidewire crossing is generally lower in intimal than subintimal angioplasty. The transvenous IVUS technique was similarly effective when the retrograde approach was selected because the transvenous IVUS catheter provided an image of the retrograde guidewire.
In this study, a guidewire was passed through the CTO lesion under both fluoroscopic and IVUS guidance, and there were no complications associated with the procedure. It is our belief that guidewire navigation with dual guidance modalities helped avoid arterial perforation.
Although ultrasound imaging was not performed to estimate venous valve dysfunction, no patients had venous aneurysms or leg edema due to venous insufficiency after the procedure. A guidewire was gently advanced to insert the IVUS catheter through a few venous valves. If resistance was encountered, the leg was massaged to open the venous valve. No patient experienced venous thrombosis or pulmonary thromboembolism associated with the procedure. The low TLR rate during midterm follow-up was similar to that reported by others 18, 19 and noteworthy considering that 42% of patients in this study underwent balloon angioplasty alone. When stenting was necessary, only a bare (uncoated) nitinol stent was used. Similarly, no drug-coated balloons were employed, though they may have advantages in transvenous IVUS-guided EVT (intimal tracking).
Insofar as contraindications are concerned, transvenous IVUS guidance cannot be done in the iliac artery because it is not completely parallel with the vein. Lesions in the anterior and posterior tibial and peroneal arteries were also excluded because the companion veins are small, and retrograde insertion of an IVUS catheter could lead to destruction of the valve.
Conclusion
Transvenous IVUS guidance is a safe technique and can provide optimal short-term results for CTO recanalization in the femoropopliteal segment. In our experience, transvenous IVUS-guided EVT facilitated intimal tracking and increased the potential for antegrade guidewire crossing. It visualized the occlusion from the SFA to the tibioperoneal trunk and optimized manipulation of the guidewire in the CTO. It would also appear to lower the risk of arterial perforation arising from subintimal balloon dilation or stent deployment, but these observations from a small singlecenter experience need corroboration to confirm the efficacy and safety of the technique.
